Explorer les evidences

5,59 mmol/lPost-menopausal women with breast cancer had significantly higher total antioxidant capacity (5.59 ± 2.38 mmol/l) compared to controls (4.43 ± 2.66 mmol/l), with P = 0.023.

Nigeriacancer du seinpublié 2021Nigerian journal of clinical practicePubMeddocument de 6 observations

26,3 %Breast lump was the second most common clinical indication, reported in 26.3% of women.

Nigeriacancer du seinobservé 2020–2021publié 2024West African journal of medicinePubMeddocument de 12 observations

78,5 %78.5% of the participants stated that they practiced breast self-examination.

Nigeriacancer du seinpublié 2023BMC women's healthPubMeddocument de 12 observations

Breast cancer is the most prevalent cancer type globally.

Nigeriacancer du seinpublié 2024Nigerian journal of clinical practicePubMeddocument de 5 observations

Plasma D-dimer and fibrinogen levels were significantly higher in breast cancer patients than in healthy controls.

Nigeriacancer du seinpublié 2021Cancer investigationPubMeddocument de 4 observations

0,41 aORParticipants with highly educated fathers were 60% less likely to have high-grade breast cancer (adjusted odds ratio 0.41; 95% confidence interval 0.20 to 0.84) compared to those with less-educated fathers.

Nigeriacancer du seinpublié 2021Annals of global healthPubMeddocument de 7 observations

18,8 %Among patients with resectable breast cancer in Nigeria between January 2010 and December 2018, 18.8% (57/303) experienced recurrence.

Nigeriacancer du seinobservé 2010–2018publié 2021International journal of cancerPubMeddocument de 12 observations

379 casesThe study recruited 379 histologically confirmed breast cancer cases and 403 controls.

Nigeriacancer du seinobservé October 2016 to May 2017publié 2022The Pan African medical journalPubMeddocument de 5 observations

78 %Between 78% and 88% of patients across Ghana, Kenya, and Nigeria completed tests for hormone receptors and HER2.

Ghana · Kenya · Nigeriacancer du seinobservé 2014 to 2017publié 2021BMJ openPubMeddocument de 13 observations

51 patientsFifty-one (85%) patients reported no positive family history of breast cancer.

Nigeriacancer du seinpublié 2025Journal of oncology pharmacy practice : official publication of the International Society PubMeddocument de 14 observations

22 patientsPatients diagnosed with breast cancer one year before the study were 22 (39.3%) of the participants.

Nigeriacancer du seinpublié 2025Journal of oncology pharmacy practice : official publication of the International Society PubMeddocument de 14 observations

80 %Pain was the most common symptom among breast cancer patients undergoing chemotherapy in Delta State, Nigeria, reported by 80% of participants.

Nigeriacancer du sein · painpublié 2026The Pan African medical journalPubMeddocument de 5 observations

1,6 odds_ratioPracticing breast self-examination was associated with a higher probability (odds ratio 1.6) of detecting lesions <2 cm.

Nigeriacancer du seinpublié 2021PloS onePubMeddocument de 6 observations

0,575 h_squaredThe APOBEC C>T somatic mutation signature had a significant heritable component (h² = 0.575, p = 0.010).

Nigeriacancer du seinpublié 2019International journal of cancereurope_pmcdocument de 4 observations

7,2 %Of those who did not receive surgery, disease progression occurred in 7.2% (n = 9/125).

Nigeriacancer du seinpublié 2026Psycho-oncologyPubMeddocument de 11 observations

73,8 %The majority of breast cancer patients presented with stage 3 disease, accounting for 73.8%.

Nigeriacancer du seinpublié 2023West African journal of medicinePubMeddocument de 8 observations

25,5 per_100000Nigeria has the highest age-standardized breast cancer mortality rate in Africa, at 25.5 per 100,000.

Nigeriacancer du seinpublié 2025BMC health services researchPubMed

26,09 %Middle-aged individuals had 26.09% knowledge about alcohol as a breast cancer risk factor.

Nigeriacancer du seinpublié 2024JCO global oncologyPubMeddocument de 12 observations

36,1 %The prevalence of psychological distress was 36.1% among 72 patients with breast cancer post-surgery in Northern Nigeria.

Nigeriacancer du seinpublié 2025BMC psychiatryPubMeddocument de 3 observations

9 %9.0% of the respondents had good general knowledge of breast cancer.

Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 7 observations

80 %In Nigeria, 80% of breast cancer is diagnosed at an advanced stage.

Nigeriacancer du seinpublié 2025JAMA network openPubMeddocument de 8 observations

281,5 daysThe median total treatment time was 281.5 days among young adult females with breast cancer in Nigeria.

Nigeriacancer du seinpublié 2025BMC cancerPubMeddocument de 11 observations

77,1 %Most participants (77.1%) reported poor treatment adherence.

Nigeriacancer du seinpublié 2026BMC cancerPubMeddocument de 8 observations

0,33 beta_coefficientIn the TCGA dataset, seven common SNPs within or near GNB5 were significantly associated with an increased proportion of APOBEC signature contribution (beta = 0.33, 95% CI = 0.21–0.45) at genome-wide significance.

Nigeriacancer du seinpublié 2019International journal of cancereurope_pmcdocument de 4 observations

33,83 %Among 3,263 breast histopathology records reviewed from 2015 to 2023, 33.83% of breast cancer cases were in middle-aged women (40–59 years).

Nigeriacancer du seinobservé 2015 to 2023publié 2025Scientific reportsPubMeddocument de 12 observations